Strategic level proton therapy patient admission planning: a Markov decision process modeling approach

Клики: 310
ID: 269428
2017
Бесплатный PDF
Метрики качества и эффективности статьи
Общее качество
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
Оценка качества ИИ
Не проанализировано
Readership in this journal
Steady

Ranked #8 of 25 articles by views in health care management science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Аннотация
A relatively new consideration in proton therapy planning is the requirement that the mix of patients treated from different categories satisfy desired mix percentages. Deviations from these percentages and their impacts on operational capabilities are of particular interest to healthcare planners. …
Ссылочный ключ
r2017healthstrategic Используйте этот ключ для автоцитирования в рукописи при использовании SciMatic Manuscript Manager или Thesis Manager
Авторы Gedik R;Zhang S;Rainwater C;;
Журнал health care management science
Год 2017
DOI
DOI не найден
URL
https://www.pubmed.gov/?cmd=Search&term=Ridvan%20Gedik
Ключевые слова
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine United States hospitalization markov chains patient admission* pmid:26810359 doi:10.1007/s10729-016-9354-6 ridvan gedik shengfan zhang chase rainwater appointments and schedules clinical decision-making* patient care planning* proton therapy*

Цитирования

Цитирования не найдены. Чтобы добавить цитирование, свяжитесь с администратором по адресу info@scimatic.org

Комментарии

Комментариев пока нет. Будьте первым, кто прокомментирует эту статью.